Zentalis Pharmaceuticals Inc (ZNTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Operating Expenses | 40,245 | 34,767 | 27,376 | 16,399 | 14,905 |
| Operating Income | -40,245 | -34,767 | -27,376 | -16,399 | -14,905 |
| Other Income | 315 | 120 | 84 | 164 | 359 |
| Pre-tax Income | -39,930 | -34,647 | -27,292 | -16,235 | -14,546 |
| Income Tax | 426 | 18 | N/A | N/A | N/A |
| Net Income Continuous | -40,356 | -34,665 | -27,292 | -16,235 | -14,546 |
| Minority Interests | -53 | -110 | -435 | -109 | -40 |
| Net Income | $-40,303 | $-34,555 | $-26,857 | $-16,126 | $-14,506 |
| EPS Basic Total Ops | 0.38 | -0.91 | -0.78 | -2.88 | -2.60 |
| EPS Basic Continuous Ops | 0.39 | -0.91 | -0.79 | -2.90 | -2.60 |
| EPS Diluted Total Ops | 0.38 | -0.91 | -0.78 | -2.88 | -2.60 |
| EPS Diluted Continuous Ops | 0.39 | -0.91 | -0.79 | -2.90 | -2.60 |
| EBITDA(a) | $-39,880 | $-34,557 | $-27,273 | $-16,361 | $-14,864 |